Results 201 to 210 of about 546,850 (281)

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

APOA1 binding protein promotes lymphatic cell fate and lymphangiogenesis by relieving caveolae-mediated inhibition of VEGFR3 signaling. [PDF]

Nat Commun
Kim JD, Chaudhary S, Chen W, Astin J, Crosier PS, Yu P, Cooke JP, Pownall HJ, Bellen HJ, Le NT, Kiss DL, Wang G, Rockson SG, Chen H, Fang L.   +14 more
europepmc   +1 more source

On the cardinality and dimension of the slices of Okamoto’s functions

Simon Baker, George Bender
openalex   +1 more source

Screening for lung cancer: A systematic review of overdiagnosis and its implications

Molecular Oncology, EarlyView.
Low‐dose computed tomography (CT) screening for lung cancer may increase overdiagnosis compared to no screening, though the risk is likely low versus chest X‐ray. Our review of 8 trials (84 660 participants) shows added costs. Further research with strict adherence to modern nodule management strategies may help determine the extent to which ...
Fiorella Karina Fernández‐Sáenz, Laura de la Torre‐Perez, David R Baldwin, Carlijn van der Aalst, Mangesh Thorat, David Ritchie, Andre L Carvalho, Carolina Espina, Ivan Solà, Carlos Canelo‐Aybar, Moira Magdalena Pissinis, Pablo Alonso‐Coello, Ana Carolina Pereira Nunes Pinto   +12 more
wiley   +1 more source

Innovations in spinal cord cell type heterogeneity across vertebrate evolution

Ignatyev Y, Papadopoulos S, Soretić M, Yeung J, Lin T, Tanaka EM, Peshkin L, Levine AJ, Gabitto MI, Sweeney LB.   +9 more
europepmc   +1 more source

Coverage Checker: A Web-Based Tool to Navigate Diabetes Coverage and Prior Authorization. [PDF]

Ann Fam Med
Kim N, Cardinal S, Gabison J, Oshman L, Rau J, Reiss J, Young L, Diez HL.   +7 more
europepmc   +1 more source

Committee on the Cardinal Spellman Award (July 2, 1947): report of chairman

, 2012
James Edward Rea
openalex   +1 more source

Estimating the size of a union of random subsets of fixed cardinality

, 2001
Michael Barot, José Antonio de la Peña
openalex   +2 more sources

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

Tuning of cortical color mechanisms revealed using steady-state visually evoked potentials. [PDF]

Imaging Neurosci (Camb)
Rozman A, Watts DJ, Somers LP, Gunel B, Racey C, Barnes K, Bosten JM.   +6 more
europepmc   +1 more source